Zeria Pharmaceutical Co Ltd
TSE:4559

Watchlist Manager
Zeria Pharmaceutical Co Ltd Logo
Zeria Pharmaceutical Co Ltd
TSE:4559
Watchlist
Price: 2 099 JPY -0.99% Market Closed
Market Cap: 92.5B JPY

Wall Street
Price Targets

Price Targets Summary
Zeria Pharmaceutical Co Ltd

Wall Street analysts forecast Zeria Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Zeria Pharmaceutical Co Ltd is 2 448 JPY with a low forecast of 2 424 JPY and a high forecast of 2 520 JPY.

Lowest
Price Target
2 424 JPY
15% Upside
Average
Price Target
2 448 JPY
17% Upside
Highest
Price Target
2 520 JPY
20% Upside
Zeria Pharmaceutical Co Ltd Competitors:
Price Targets
PAHC
Phibro Animal Health Corp
17% Upside
2M7C
China Medical System Holdings Ltd
29% Upside
JBCHEPHARM
J B Chemicals and Pharmaceuticals Ltd
13% Upside
VY4
SNDL Inc
266% Upside
GS71
GSK plc
1% Upside
4521
Kaken Pharmaceutical Co Ltd
14% Upside

Revenue
Forecast

Revenue Estimate
Zeria Pharmaceutical Co Ltd

For the last 13 years the compound annual growth rate for Zeria Pharmaceutical Co Ltd's revenue is 4%. The projected CAGR for the next 3 years is 4%.

4%
Past Growth
4%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Zeria Pharmaceutical Co Ltd

Operating Income forecast
is not available for
Zeria Pharmaceutical Co Ltd

Net Income
Forecast

Net Income Estimate
Zeria Pharmaceutical Co Ltd

For the last 13 years the compound annual growth rate for Zeria Pharmaceutical Co Ltd's net income is 10%. The projected CAGR for the next 3 years is 6%.

10%
Past Growth
6%
Estimated Growth
Estimates Accuracy
-13%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Zeria Pharmaceutical Co Ltd's stock price target?
Price Target
2 448 JPY

According to Wall Street analysts, the average 1-year price target for Zeria Pharmaceutical Co Ltd is 2 448 JPY with a low forecast of 2 424 JPY and a high forecast of 2 520 JPY.

What is Zeria Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
4%

For the last 13 years the compound annual growth rate for Zeria Pharmaceutical Co Ltd's revenue is 4%. The projected CAGR for the next 3 years is 4%.

What is Zeria Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
6%

For the last 13 years the compound annual growth rate for Zeria Pharmaceutical Co Ltd's net income is 10%. The projected CAGR for the next 3 years is 6%.

Back to Top